Fonte: Journal of Cachexia, Sarcopenia and Muscle. Unidades: HU, ICB
Assuntos: BIOLOGIA CELULAR, FARMACOLOGIA, CAQUEXIA, NEOPLASIAS, ESTRESSE OXIDATIVO, CITOCINAS, MACRÓFAGOS, INTERFERONS, INTERLEUCINA 8, PROTEÍNAS QUINASES
ABNT
LIMA, Joanna Dark Carola Correia et al. Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia. Journal of Cachexia, Sarcopenia and Muscle, v. 10, n. 5, p. 1045-1059, 2019Tradução . . Disponível em: https://doi.org/10.1002/jcsm.12441. Acesso em: 18 ago. 2024.APA
Lima, J. D. C. C., Simões, E., Castro, G. de, Morais, M. R. P. T., Matos-Neto, E. M. de, Alves, M. J., et al. (2019). Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia. Journal of Cachexia, Sarcopenia and Muscle, 10( 5), 1045-1059. doi:10.1002/jcsm.12441NLM
Lima JDCC, Simões E, Castro G de, Morais MRPT, Matos-Neto EM de, Alves MJ, Pinto NI, Figueredo RG, Zorn TMT, Felipe-Silva A, Tokeshi F, Otoch JP, Alcântara PSM de, Cabral FJ, Ferro ES, Laviano A, Seelaender MCL. Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia [Internet]. Journal of Cachexia, Sarcopenia and Muscle. 2019 ; 10( 5): 1045-1059.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1002/jcsm.12441Vancouver
Lima JDCC, Simões E, Castro G de, Morais MRPT, Matos-Neto EM de, Alves MJ, Pinto NI, Figueredo RG, Zorn TMT, Felipe-Silva A, Tokeshi F, Otoch JP, Alcântara PSM de, Cabral FJ, Ferro ES, Laviano A, Seelaender MCL. Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia [Internet]. Journal of Cachexia, Sarcopenia and Muscle. 2019 ; 10( 5): 1045-1059.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1002/jcsm.12441